Positron Emission Tomography (PET) in Germ Cell Tumors (GCT)
Authors:
- 22 November 2008
- book chapter
- Published by Springer Nature
- p. 305-313
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission TomographyJournal of Clinical Oncology, 2005
- Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2005
- Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on OutcomeJournal of Clinical Oncology, 2005
- 2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET TrialJournal of Clinical Oncology, 2004
- Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinomaCancer, 2002
- Detection of residual tumours in postchemotherapy testicular cancer by FDG-PETEuropean Journal of Cancer, 1997
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Accuracy of Clinical Staging in Non-Seminomatous Testicular Cancer—a Single Centre Experience of Retroperitoneal Lymph Node DissectionScandinavian Journal of Urology and Nephrology, 1995
- The Role of Retroperitoneal Lymphadenectomy in Clinical Stage B Testis Cancer: The Indiana University Experience (1965 to 1989)Journal of Urology, 1995
- How Cells Absorb GlucoseScientific American, 1992